Tema Oncology Etf Market Value

CANC Etf   25.86  0.04  0.15%   
Tema Oncology's market value is the price at which a share of Tema Oncology trades on a public exchange. It measures the collective expectations of Tema Oncology ETF investors about its performance. Tema Oncology is trading at 25.86 as of the 22nd of February 2025, a 0.15 percent decrease since the beginning of the trading day. The etf's open price was 25.9.
With this module, you can estimate the performance of a buy and hold strategy of Tema Oncology ETF and determine expected loss or profit from investing in Tema Oncology over a given investment horizon. Check out Tema Oncology Correlation, Tema Oncology Volatility and Tema Oncology Alpha and Beta module to complement your research on Tema Oncology.
Symbol

The market value of Tema Oncology ETF is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Oncology's value that differs from its market value or its book value, called intrinsic value, which is Tema Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Oncology's market value can be influenced by many factors that don't directly affect Tema Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tema Oncology 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tema Oncology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tema Oncology.
0.00
04/28/2024
No Change 0.00  0.0 
In 9 months and 27 days
02/22/2025
0.00
If you would invest  0.00  in Tema Oncology on April 28, 2024 and sell it all today you would earn a total of 0.00 from holding Tema Oncology ETF or generate 0.0% return on investment in Tema Oncology over 300 days. Tema Oncology is related to or competes with Fidelity Covington, Fidelity Covington, Fidelity Covington, Morningstar Unconstrained, Thrivent High, Via Renewables, and T Rowe. Tema Oncology is entity of United States More

Tema Oncology Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tema Oncology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tema Oncology ETF upside and downside potential and time the market with a certain degree of confidence.

Tema Oncology Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Tema Oncology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tema Oncology's standard deviation. In reality, there are many statistical measures that can use Tema Oncology historical prices to predict the future Tema Oncology's volatility.
Hype
Prediction
LowEstimatedHigh
24.5925.8727.15
Details
Intrinsic
Valuation
LowRealHigh
24.5325.8127.09
Details

Tema Oncology ETF Backtested Returns

Tema Oncology ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0269, which indicates the etf had a -0.0269 % return per unit of risk over the last 3 months. Tema Oncology ETF exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tema Oncology's Variance of 1.84, risk adjusted performance of (0.01), and Coefficient Of Variation of (4,247) to confirm the risk estimate we provide. The entity has a beta of 0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tema Oncology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tema Oncology is expected to be smaller as well.

Auto-correlation

    
  -0.62  

Very good reverse predictability

Tema Oncology ETF has very good reverse predictability. Overlapping area represents the amount of predictability between Tema Oncology time series from 28th of April 2024 to 25th of September 2024 and 25th of September 2024 to 22nd of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tema Oncology ETF price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Tema Oncology price fluctuation can be explain by its past prices.
Correlation Coefficient-0.62
Spearman Rank Test-0.69
Residual Average0.0
Price Variance1.29
Tema ReturnsTema Lagged ReturnsDiversified AwayTema ReturnsTema Lagged ReturnsDiversified Away100%

Tema Oncology ETF lagged returns against current returns

Autocorrelation, which is Tema Oncology etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tema Oncology's etf expected returns. We can calculate the autocorrelation of Tema Oncology returns to help us make a trade decision. For example, suppose you find that Tema Oncology has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
JavaScript chart by amCharts 3.21.15OctNovDec2025Feb-10%-5%0%5%10%
JavaScript chart by amCharts 3.21.15Volume Lagged Volume Prices Lagged Prices
       Timeline  

Tema Oncology regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tema Oncology etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tema Oncology etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tema Oncology etf over time.
   Current vs Lagged Prices   
JavaScript chart by amCharts 3.21.15OctNovDec2025Feb25.025.526.026.527.027.528.028.5
JavaScript chart by amCharts 3.21.15Regression Prices Lagged Regression Prices
       Timeline  

Tema Oncology Lagged Returns

When evaluating Tema Oncology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tema Oncology etf have on its future price. Tema Oncology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tema Oncology autocorrelation shows the relationship between Tema Oncology etf current value and its past values and can show if there is a momentum factor associated with investing in Tema Oncology ETF.
   Regressed Prices   
JavaScript chart by amCharts 3.21.15MayJulSepNov20252526272829
JavaScript chart by amCharts 3.21.15Lagged Returns Returns
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Tema Oncology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tema Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tema Oncology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Tema Oncology Etf:
Check out Tema Oncology Correlation, Tema Oncology Volatility and Tema Oncology Alpha and Beta module to complement your research on Tema Oncology.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Tema Oncology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Tema Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tema Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...